2025 Fellows Courses

Lunch Program: Advancing CHD Outcomes: Lifetime Management Considerations for Patients with Dysfunctional RVOT

Join us as we discuss Optimizing care for your CHD Patients with the Edwards Pulmonic Portfolio. From the SAPIEN valve, to Alterra Adaptive Prestent, and our life-saving Atrial Septostomy Ballon, attendees will explore current indications, procedural considerations and strategies, and the advantages of using the SAPIEN 3 and Alterra in specific complex RVOT anatomy. We will guide you through the latest evidence and real-world application of our Pulmonic Devices; from COMPASSION S3 and ALTERRA Clinical trial data to lifetime management considerations, you’ll gain practical insights to shape your approach to RVOT dysfunction. Grab lunch and engage in discussions. 

Sponsored by Edwards.

Explore the Evidence: A look at the Edwards SAPIEN 3 Pulmonic Portfolio
Jenny E. Zablah, M.D., FSCAI, University of Colorado Anschutz Medical Campus, Aurora, CO
SAPIEN Pulmonic Valve: Procedural and Lifetime Considerations
Zachary Steinberg, M.D., FSCAI, University of Washington Medical Center - Montlake, Seattle, WA